Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemiaPatricia Stow, Dario Campana, Geoffrey Neale et al.|Blood|2010Cited by 159
Integrative Molecular Analysis of Patients With Advanced and Metastatic CancerVerena Sailer, Olivier Elemento, Kenneth Eng et al.|JCO Precision Oncology|2019Cited by 46